tons of research on this, seems to be useful to cancer research for
prostate and esophagus cancers, widely available for research from a bunch
of places for that though not pharmaceutical grade yet.
https://www.nature.com/articles/srep35196
lots of press are picking up the report, hardly buried...
https://www.dailymail.co.uk/news/article-9213723/Prostate-cancer-drug-effective-antiviral-against-coronavirus-common-cold.html
On Sun, Nov 21, 2021 at 10:11 PM Domingo Pichardo <
dmarc-noreply@xxxxxxxxxxxxx> wrote:
"In this ground-breaking study, the team of experts found that the
plant-derived antiviral, at small doses, triggers a highly effective
broad-spectrum host-centered antiviral innate immune response against three
major types of human respiratory viruses — including Covid-19"
"Plant derived" meaning, not patentable and therefore, not lucrative! Look
at Ivermectin and HCQ, old, safe drugs but with long exired patents which
they blocked from day one. They will never let this BIG News get out! The
MSM will never talk about this... Pfizer already has a patent on its own
Corona virus anitiviral... they are dispicable!
A true lover of wisdom has hands too busy to hold on to anything! He
learns by doing and every pebble in the path becomes her teacher! Oink
On Sunday, November 21, 2021, 09:19:17 PM EST, Mouse wrote:
https://scitechdaily.com/powerful-antiviral-treatment-for-covid-19-discovered-that-could-change-how-epidemics-are-managed/
<https://forum.cigar.com/home/leaving?allowTrusted=1&target=https%3A%2F%2Fscitechdaily.com%2Fpowerful-antiviral-treatment-for-covid-19-discovered-that-could-change-how-epidemics-are-managed%2F>
papers here:
https://www.mdpi.com/search?q=thapsigargin&journal=viruses
<https://forum.cigar.com/home/leaving?allowTrusted=1&target=https%3A%2F%2Fwww.mdpi.com%2Fsearch%3Fq%3Dthapsigargin%26journal%3Dviruses>
Open AccessArticle
Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory
Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus
by Sarah Al-Beltagi,Cristian Alexandru Preda,Leah V. Goulding,Joe
James,Juan Pu,Paul Skinner,Zhimin Jiang,Belinda Lei ****,Jiayun Yang,Ashley
C. Banyard,Kenneth H. Mellits,Pavel Gershkovich,Christopher J.
Hayes,Jonathan Nguyen-Van-Tam,Ian H. Brown,Jinhua Liu andKin-Chow Chang
Viruses 2021, 13(2), 234; https://doi.org/10.3390/v13020234
<https://forum.cigar.com/home/leaving?allowTrusted=1&target=https%3A%2F%2Fdoi.org%2F10.3390%2Fv13020234>
-
03 Feb 2021
Cited by 4 | Viewed by 17879
Abstract The long-term control strategy of SARS-CoV-2 and other major
respiratory viruses needs to include antivirals to treat acute infections,
in addition to the judicious use of effective vaccines. Whilst COVID-19
vaccines are being rolled out for mass vaccination, the modest number of
antivirals [...] Read more.
Open AccessArticle
Thapsigargin at Non-Cytotoxic Levels Induces a Potent Host Antiviral
Response that Blocks Influenza A Virus Replication
by Leah V. Goulding,Jiayun Yang,Zhimin Jiang,Hongyu Zhang,Daniel
Lea,Richard D. Emes,Tania Dottorini,Juan Pu,Jinhua Liu andKin-Chow Chang
Viruses 2020, 12(10), 1093; https://doi.org/10.3390/v12101093
<https://forum.cigar.com/home/leaving?allowTrusted=1&target=https%3A%2F%2Fdoi.org%2F10.3390%2Fv12101093>
-
27 Sep 2020
Cited by 5 | Viewed by 3664
Abstract Influenza A virus is a major global pathogen of humans, and there
is an unmet need for effective antivirals. Current antivirals against
influenza A virus directly target the virus and are vulnerable to
mutational resistance. Harnessing an effective host antiviral response is
an [...] Read more.
(This article belongs to the Section Viral Immunology, Vaccines, and
Antivirals)
--
<:3 )~
